The Federal Government says it spends approximately 150 million dollars annually on vaccine procurement while expanding malaria vaccination efforts across more states.
Dr Muyi Aina, Executive Director of the National Primary Health Care Development Agency (NPHCDA), disclosed this on Tuesday during the agency’s first quarterly media briefing for 2026 in Abuja.
Aina explained that funding for vaccines is sourced from federal government allocations and development partners, particularly Gavi. However, he noted that donor contributions have been declining in recent years.
“Countries are now expected to increase domestic financing as global donor resources continue to shrink,” he said.
He added that vaccine financing goes beyond procurement to include outbreak response and logistics such as syringes, waste management systems, incinerators, and cold chain equipment. Operational costs for nationwide immunisation delivery also account for a significant portion of government spending.
On malaria control, Aina said Nigeria has expanded its malaria vaccine rollout from the initial pilot states of Bayelsa and Kebbi to include Bauchi and Ondo, following readiness assessments.
He noted that the malaria vaccine requires a four-dose schedule, which poses a challenge in ensuring full compliance among beneficiaries.
“What is unique about the malaria vaccine is that it requires four doses, and ensuring children return for all doses remains a key challenge,” he said.
Providing updates on progress, Aina disclosed that Bayelsa has recorded about 68,000 doses administered, Kebbi 153,000, Bauchi 66,000, and Ondo over 7,000 doses.
